There are currently two classifications of Alzheimer's disease, one is by age, and it develops before the age of 65 and is called Alzheimer's disease. It develops after age 65 and is called social senile dementia.This type is The most common type is the one with the highest incidence. There is also a classification based on the presence or absence of family history, one is divided into sporadic hair types, and the other is divided into family types, which are more common in Alzheimer's disease.
<em>The most interesting results obtained in animal models of passive immunotherapies developed according to the “amyloid-beta cascade hypothesis” and the “Tau hypothesis” are monoclonal antibodies that directly or indirectly target Aβ plaques or neurofibrillary tangles. Unfortunately, these therapeutic antibodies (https://www.creativebiomart.net/alzheimacy/therapeutics/therapeutic-antibody/) cannot replicate their promising effects on humans at the clinical phase. Despite this, we still hope to learn from these failures and to explore new pathways. The great effects obtained in animals with passive immunotherapy suggest that this technology may be an important key to curative treatment. The remaining challenge is to find a way to achieve the same encouraging results for humans. Alzheimacy expects to join hands with global partners to focus on the development of therapeutic antibodies for Alzheimer’s disease (AD) and continue to fight against this disease.</em>
The continents could have gotten so far because of plate tectonic movement. We know that the plates are always moving so if these plates were very active then it would have caused supercontinent pangea to drift apart. This process must have taken more than a million years to happen.
